XERS
Xeris Biopharma Holdings Inc
NASDAQ · Pharmaceuticals
$7.01
+0.10 (+1.45%)
Open$7.00
Previous Close$6.91
Day High$7.10
Day Low$6.93
52W High$10.08
52W Low$3.45
Volume—
Avg Volume1.36M
Market Cap1.21B
P/E Ratio—
EPS$-0.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+565.5% upside
Current
$7.01
$7.01
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 239.39M | 149.64M | 193.05M |
| Net Income | -64,639,302 | -36,364,152 | 59.12M |
| Profit Margin | -27.0% | -25.7% | 30.6% |
| EBITDA | -24,862,600 | -14,764,014 | 68.71M |
| Free Cash Flow | — | — | 33.47M |
| Rev Growth | +60.0% | +60.0% | -5.7% |
| Debt/Equity | 4.14 | 4.14 | 0.70 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |